3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Myelodysplastic Syndromes
13
Leukemia, Myeloid, Acute
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Leukemia
7
Hematologic Neoplasms
7
Lymphoma, Non-Hodgkin
5
Lymphoma
5
Primary Immunodeficiency Diseases
3
Multiple Myeloma
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Cytopenia
3
Anemia, Aplastic
3
Thalassemia
2
Osteopetrosis
2
Hodgkin Disease
2
Hemoglobinopathies
2
Fanconi Anemia
2
Anemia, Sickle Cell
2
Anemia, Diamond-Blackfan
2
Anemia
2
Uveal Melanoma
1
Neoplasms, Plasma Cell
1
Neoplasm, Residual
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Lymphoproliferative Disorders
1
Lymphohistiocytosis, Hemophagocytic
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Biphenotypic, Acute
1
Interventions
Tacrolimus
6
Busulfan
6
fludarabine phosphate
4
fludarabine
4
Peripheral Blood Stem Cell Transplantation
4
Mycophenolic Acid
4
Cyclophosphamide
4
Whole-Body Irradiation
3
ponatinib
2
Patient Reported Outcome Measures
2
Mesna
2
Melphalan
2
Early Intervention, Educational
2
Bone Marrow Transplantation
2
Antilymphocyte Serum
2
Alemtuzumab
2
trametinib
1
ruxolitinib
1
ethanolamine oleate
1
dabrafenib
1
Trimethoprim, Sulfamethoxazole Drug Combination
1
Trimethoprim
1
Tinzaparin
1
Thiotepa
1
Sulfamethoxazole
1
Stem Cell Transplantation
1
Sodium Chloride
1
Sirolimus
1
Saline Solution, Hypertonic
1
Saline Solution
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoproliferative Disorders
×
AP 1903 reagent
×
Myeloid
×
Clear all
NCT01494103
2025-07-11
DOTTI
Baylor College of Medicine
Phase 1
Active not recruiting
15 enrolled